Israel - Ibrani - Ministry of Health

comex ltd - meloxicam - תרחיף - meloxicam 1.5 mg/ml

Israel - Ibrani - Ministry of Health

gsk consumer healthcare, israel ltd - xylometazoline hydrochloride - תמיסה לאף - xylometazoline hydrochloride 0.05 %w/v - xylometazoline - xylometazoline - rapid symptomatic relief of nasal decongestion up to 10 hours.

Israel - Ibrani - Ministry of Health

gsk consumer healthcare, israel ltd - xylometazoline hydrochloride - תמיסה לאף - xylometazoline hydrochloride 0.1 %w/v - xylometazoline - xylometazoline - rapid relief of nasal congestion for up to ten hours.

Israel - Ibrani - Ministry of Health

perrigo israel agencies ltd - latanoprost - טיפות עיניים - latanoprost 0.05 mg / 1 ml - latanoprost

Israel - Ibrani - Ministry of Health

perrigo israel agencies ltd - latanoprost; timolol as maleate - טיפות עיניים - timolol as maleate 5 mg / 1 ml; latanoprost 0.05 mg / 1 ml - timolol

Israel - Ibrani - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 400 mcg/actuation - fluticasone - fluticasone - flixonase nasule drops are indicated for the regular treatment of nasal polyps and associated symptoms of nasal obstruction.

Israel - Ibrani - Ministry of Health

abbvie biopharmaceuticals ltd, israel - epinastine hydrochloride - תמיסה לעין - epinastine hydrochloride 0.05 %w/v - epinastine - epinastine - treatment of the symptoms of seasonal allergic conjunctivitis.

Israel - Ibrani - Ministry of Health

truemed ltd, israel - follitropin alfa - תמיסה להזרקה - follitropin alfa 600 iu / 1 ml - follitropin alfa

Israel - Ibrani - Ministry of Health

merck serono ltd - follitropin alfa - תמיסה להזרקה - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - gonal-f followed by chorionic gonadotrophin (hcg), is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf), gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermat

Israel - Ibrani - Ministry of Health

merck serono ltd - follitropin alfa; lutropin alfa - אבקה וממס להכנת תמיסה להזרקה - follitropin alfa 150 iu; lutropin alfa 75 iu - follitropin alfa - follitropin alfa - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh level < 1.2 iu/l.